The short version
BPC-157 has been investigated in rat Achilles-tendon injury and cultured tendon-cell experiments. That early research belongs in a different category from a human treatment trial.
An investigational profile is not an endorsement or a finding of safety.
Names you may see
Compound names, research identifiers, brand names and informal shorthand serve different purposes.
- BPC-157
- Entry name · The name used for this encyclopedia topic.
- BPC157
- Recorded name variation · A name associated with this entry; check exact ingredient, modification, formulation and context.
Similar names do not establish identical ingredients, molecular variants, product quality or interchangeable preparations. A blend nickname may describe different formulas.
Things worth checking
How much can a two-person safety pilot tell us?
Both participants had received intravenous BPC-157 before the pilot. No reported side effects over three days cannot exclude uncommon or delayed harms. Ask what longer and more representative evidence supports a safety claim.
Study-specific context · Original two-person human pilot ↗
Questions to bring to a clinician or pharmacist
- Which findings apply to my goal and medical history?
- Could my medicines, supplements, or other compounds change the assessment?
- What monitoring, if any, would inform a decision—and what symptoms would need evaluation?
Monitoring is individual. Normal bloodwork does not establish that a compound or preparation is safe.
Delivery methods
How a compound is delivered can change the question being studied. These selected examples explain the route, purpose and evidence limits; they do not establish an appropriate route for an individual.
Oral tablets · registered human study
Registered study · not an efficacy result
- Why it was studied or discussed
- Safety and how the body handles the compound in healthy volunteers.
- What this means for the reader
- FDA’s 2026 assessment describes an oral phase 1 record without posted results. This does not establish treatment benefit for digestive conditions.
Oral and abdominal injection · animal gut model
Animal research
- Why it was studied or discussed
- Healing of an experimentally created abnormal connection between bowel and bladder in rats.
- What this means for the reader
- The study used oral treatment in drinking water or injection into the abdominal cavity. This does not establish that oral BPC-157 treats a human digestive condition.
Abdominal injection · animal tendon model
Animal research
- Why it was studied or discussed
- Tendon-to-bone healing after experimental Achilles detachment in rats.
- What this means for the reader
- The injection was into the abdominal cavity, not a human injection under the skin near an injury. Animal findings do not establish a preferred human route for tendon recovery.
Intravenous infusion · human pilot
Uncontrolled human pilot
- Why it was studied or discussed
- Short-term safety observations in two previously exposed adults.
- What this means for the reader
- This pilot did not measure tendon recovery or digestive benefit. Its route cannot be treated as evidence for other injection methods.
This is a selected comparison, not an exhaustive list of preparations or a guide to administering them. The clinical summaries below identify the route used in each study.
Clinical research
Small human reports exist. The selected safety pilot below is uncontrolled and does not establish injury-healing benefit or general safety.
Two-person intravenous safety pilot (2025)
Summary based on: Published abstract and full-text disclosures
- Study design
- Uncontrolled pilot with observations across three days; not a randomized trial.
- Who was studied
- Two adults aged 58 and 68; both had previously received intravenous BPC-157.
- Route and preparation
- Intravenous infusion; two previously exposed participants.
- What was compared
- Two intravenous exposures with blood tests and vital-sign checks. There was no placebo or untreated comparison group.
- What researchers found
- The authors reported no side effects or measurable changes in the tested organ and blood-glucose biomarkers during the short observation period.
- What this leaves unanswered
- Two previously exposed participants and three days of observation cannot establish general safety, exclude uncommon or delayed harms, or demonstrate treatment benefit for an injury. Other routes and preparations require separate evidence.
- Funding context
- The authors report no funding and declare no conflicts. Those disclosures do not remove the study’s design limitations.
Research terms in everyday language ↗
Selected human pilot and animal-paper summaries are included. Other human reports and a broader full-text evidence review remain pending.
Read findings in the context of the exact product or preparation, the people studied, and the outcome measured. These draft profiles are starting points, rather than complete systematic reviews.
Community research
Structured community reports can help identify questions worth studying. They are considered separately from controlled studies, with their limitations kept visible.
No community reports published yet.
This profile has no published community dataset. We do not infer a trend or a benefit from missing reports.
How community research will work ↗What we will document about community advice
- The advice
- What people recommend, with dated sources and the scope of the discussions examined.
- The reasoning
- Why contributors believe it helps, without treating that explanation as an established mechanism.
- The evidence
- What supports the claim, contradicts it, or has not been tested.
- The cautions
- Possible downsides, conflicting experiences, and questions for a clinician or pharmacist.
No recommendation or community consensus is established by this framework. Descriptions of how common advice is will need documented source coverage.
A closer look
- Classification
- Research profile
- Name variations
- Names you may see and important distinctions
- Source type
- Regulatory safety notice
- Reference jurisdiction
- United States
Interpret the source in the context of the preparation and route it discusses. A regulatory notice and a controlled clinical trial answer different questions.
Rat tendon and cultured tendon-cell research (2003)
Researchers studied severed Achilles tendons in rats and tendon cells in the laboratory, reporting improved healing measures. These findings cannot establish benefit for a person with a tendon injury.
Read the original paper ↗This first design edition reserves space for study-by-study summaries, definitions, and technical references as each profile receives editorial review.
Go to the source
Study cards identify whether the summary uses an abstract, full text, or an agency assessment. Follow the linked sources for their original context.
Source reference · Checked 7 November 2026 · Opens in a new tab
Original pilot paper; funding and conflict declarations are author-reported.
For athletes: competition rules are a separate check ↗